Palonosetron (INN, trade name Aloxi) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV). It is used for the control of delayed CINV—nausea and vomiting and there are tentative data to suggest that it may be more effective than granisetron. Palonosetron is ...
Information for patients and caregivers about ALOXI® (palonosetron HCl).
Learn about Aloxi (Palonosetron hydrochloride) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.
Easy to read patient leaflet for Palonosetron. Includes indications, proper use, special instructions, precautions, and possible side effects.
Palonosetron (INN, trade name Aloxi) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV). It is the most effective of the 5-HT3 antagonists in controlling delayed CINV nausea and vomiting that appear more than 24 hours after the first dose of a course of ...
Jan 15, 2015 ... Palonosetron Injection: learn about side effects, dosage, special precautions, and more on MedlinePlus.
May 6, 2010 ... This page contains brief information about palonosetron hydrochloride and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
It is freely soluble in water, soluble in propylene glycol, and slightly soluble in ethanol and 2-propanol. Aloxi injection is a sterile, clear, colorless, non- pyrogenic, isotonic, buffered solution for intravenous administration. Each 5-ml vial of Aloxi injection contains 0.25 mg palonosetron base as hydrochloride, 207.5 mg mannitol ...
Medscape - Antiemetic dosing for Aloxi (palonosetron), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost information.